BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 63 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,356,000 | -66.8% | 859,826 | -40.7% | 0.04% | -59.3% |
| Q4 2021 | $7,103,000 | +5.2% | 1,449,494 | +171.4% | 0.09% | +2.2% |
| Q3 2021 | $6,755,000 | -18.2% | 534,000 | 0.0% | 0.09% | -19.8% |
| Q2 2021 | $8,256,000 | -22.3% | 534,000 | +65.4% | 0.11% | -29.3% |
| Q1 2021 | $10,628,000 | – | 322,944 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $23,927,000 | 8.46% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $14,762,000 | 4.72% |
| Novo Holdings A/S | 4,503,991 | $56,975,000 | 2.95% |
| Vivo Capital, LLC | 3,871,291 | $48,972,000 | 2.20% |
| Sofinnova Investments, Inc. | 2,754,437 | $34,844,000 | 2.06% |
| Samsara BioCapital, LLC | 737,459 | $9,329,000 | 1.46% |
| Ally Bridge Group (NY) LLC | 257,267 | $3,254,000 | 0.96% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $9,102,000 | 0.68% |
| Rock Springs Capital Management LP | 1,649,248 | $20,863,000 | 0.44% |
| RA Capital Management | 2,378,325 | $30,086,000 | 0.42% |